Doxazosin NDC 60505-0093

NDC codes

FDA NDC Directory

Product NDC (as listed)60505-0093Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60505-0093Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60505-0093-0	60505009300	100 TABLET in 1 BOTTLE (60505-0093-0)Marketed from Jul 14, 2011
60505-0093-1	60505009301	1000 TABLET in 1 BOTTLE (60505-0093-1)Marketed from Jul 14, 2011

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Doxazosin
Generic name (nonproprietary): doxazosin
Active ingredients: Doxazosin mesylate — 1 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Apotex Corp.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075580
Marketing start: Jul 14, 2011
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha-Antagonists (Mechanism)
Identifiers: Product ID 60505-0093_81f80a89-6a61-35db-36ad-3cb9d7ecfbdcSPL ID 81f80a89-6a61-35db-36ad-3cb9d7ecfbdc
Pharmacologic class: alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460505009300 followed by a unit qualifier and the quantity

Package 60505-0093-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 075580

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075580
Product	Strength	Form · route	Labeler	Product NDC
Doxazosin	Doxazosin mesylate 1 mg/1	TabletOral	Northwind Health Company, LLC	51655-476
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	Cardinal Health 107, LLC	55154-7996
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-043
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	AvKARE	42291-258
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	AvKARE	42291-259
Doxazosin	Doxazosin mesylate 8 mg/1	TabletOral	AvKARE	42291-260
Doxazosin	Doxazosin mesylate 1 mg/1	TabletOral	Major Pharmaceuticals	0904-5522
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	Major Pharmaceuticals	0904-5523
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	NuCare Pharmaceuticals, Inc.	68071-3298
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	NuCare Pharmaceuticals, Inc.	68071-3341
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	Major Pharmaceuticals	0904-5524
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-153
Doxazosin	Doxazosin mesylate 8 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-160
Doxazosin	Doxazosin mesylate 8 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-878
Doxazosin	Doxazosin mesylate 1 mg/1	TabletOral	American Health Packaging	68084-836
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	American Health Packaging	68084-851
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	American Health Packaging	68084-862
Doxazosin	Doxazosin mesylate 4 mg/1	TabletOral	REMEDYREPACK INC.	70518-4031
Doxazosin	Doxazosin mesylate 1 mg/1	TabletOral	A-S Medication Solutions	50090-0701
Doxazosin	Doxazosin mesylate 2 mg/1	TabletOral	A-S Medication Solutions	50090-0704

Showing 20 of 33.